MetaADEDB 2.0 @ LMMD
Risedronic Acid
(DRFDPXKCEWYIAW-UHFFFAOYSA-M)
Structure
SMILES
OC(P(=O)(O)O)(P(=O)(O)[O-])Cc1cccnc1.[Na+]
Molecular Formula:
C7H10NNaO7P2
Molecular Weight:
305.094
Log P:
0.0638
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
4
TPSA:
170.63
CAS Number(s):
115436-72-1; 122458-82-6; 934544-85-1
Synonym(s)
1.
Risedronic Acid
2.
1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate
3.
2-(3-pyridinyl)-1-hydroxyethylidene-bisphosphonate
4.
2-(3-pyridinyl)-1-hydroxyethylidenebisphosphonate
5.
Actonel
6.
Atelvia
7.
Bisphosphate Risedronate Sodium
8.
Risedronate
9.
Risedronate Sodium
10.
Risedronic Acid, Monosodium Salt
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1ArthralgiaFAERS: 337
Canada Vigilance: 45
Canada Vigilance
US FAERS
2MyalgiaFAERS: 217
Canada Vigilance: 24
Canada Vigilance
US FAERS
3Bone painFAERS: 181
Canada Vigilance: 22
Canada Vigilance
US FAERS
4Back PainFAERS: 157
Canada Vigilance: 17
Canada Vigilance
US FAERS
5PainFAERS: 154
Canada Vigilance: 22
Canada Vigilance
US FAERS
6HeadacheFAERS: 121
Canada Vigilance: 26
Canada Vigilance
US FAERS
7NauseaFAERS: 121
Canada Vigilance: 36
Canada Vigilance
US FAERS
8ChillsFAERS: 106
Canada Vigilance: 10
Canada Vigilance
US FAERS
9Chest PainFAERS: 104
Canada Vigilance: 16
Canada Vigilance
US FAERS
10Atypical femur fractureFAERS: 96
Canada Vigilance: 5
Canada Vigilance
US FAERS
11FatigueFAERS: 79
Canada Vigilance: 14
Canada Vigilance
US FAERS
12DizzinessFAERS: 77
Canada Vigilance: 22
Canada Vigilance
US FAERS
13VomitingFAERS: 77
Canada Vigilance: 11
Canada Vigilance
US FAERS
14Neck PainFAERS: 67
Canada Vigilance: 5
Canada Vigilance
US FAERS
15MalaiseFAERS: 61
Canada Vigilance: 8
Canada Vigilance
US FAERS
16Musculoskeletal PainFAERS: 61
Canada Vigilance: 8
Canada Vigilance
US FAERS
17AstheniaFAERS: 59
Canada Vigilance: 8
Canada Vigilance
US FAERS
18Feeling abnormalFAERS: 57US FAERS
19DyspepsiaFAERS: 56
Canada Vigilance: 17
Canada Vigilance
US FAERS
20Abdominal discomfortFAERS: 48
Canada Vigilance: 21
Canada Vigilance
US FAERS
21AbasiaFAERS: 39US FAERS
22Musculoskeletal stiffnessFAERS: 39
Canada Vigilance: 3
Canada Vigilance
US FAERS
23Joint swellingFAERS: 37
Canada Vigilance: 2
Canada Vigilance
US FAERS
24Musculoskeletal chest painFAERS: 37
Canada Vigilance: 4
Canada Vigilance
US FAERS
25Activities of daily living impairedFAERS: 35US FAERS
26Abdominal PainFAERS: 32
Canada Vigilance: 14
Canada Vigilance
US FAERS
27Impaired work abilityFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
28Pathological fractureFAERS: 32
Canada Vigilance: 4
Canada Vigilance
US FAERS
29TremorFAERS: 32
Canada Vigilance: 3
Canada Vigilance
US FAERS
30Drug ineffectiveFAERS: 29
Canada Vigilance: 12
Canada Vigilance
US FAERS
31HypersensitivityFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
32InfluenzaFAERS: 25US FAERS
33Weight decreasedFAERS: 25
Canada Vigilance: 4
Canada Vigilance
US FAERS
34Chest discomfortFAERS: 24
Canada Vigilance: 4
Canada Vigilance
US FAERS
35Eye painFAERS: 22
Canada Vigilance: 12
Canada Vigilance
US FAERS
36ArthritisFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
37Atrial FibrillationFAERS: 21
Canada Vigilance: 3
Canada Vigilance
US FAERS
38ToothacheFAERS: 21
Canada Vigilance: 3
Canada Vigilance
US FAERS
39Osteonecrosis of JawFAERS: 20
Canada Vigilance: 4
Canada Vigilance
US FAERS
40AlopeciaFAERS: 18US FAERS
41DiscomfortFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
42FlatulenceFAERS: 18
Canada Vigilance: 7
Canada Vigilance
US FAERS
43OsteomyelitisFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
44PruritusFAERS: 18
Canada Vigilance: 4
Canada Vigilance
US FAERS
45ConstipationFAERS: 17
Canada Vigilance: 4
Canada Vigilance
US FAERS
46ErythemaFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
47HypophagiaFAERS: 17US FAERS
48PalpitationsFAERS: 17
Canada Vigilance: 5
Canada Vigilance
US FAERS
49PhotophobiaFAERS: 17
Canada Vigilance: 4
Canada Vigilance
US FAERS
50Tooth ExtractionFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
51Oropharyngeal painFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
52UrticariaFAERS: 15
Canada Vigilance: 7
Canada Vigilance
US FAERS
53EructationFAERS: 14US FAERS
54InflammationFAERS: 14US FAERS
55Burning sensationFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
56DehydrationFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
57Middle insomniaFAERS: 13US FAERS
58OsteoporosisFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
59AnxietyFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
60Bone density decreasedFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
61Low turnover osteopathyFAERS: 12US FAERS
62BedriddenFAERS: 11US FAERS
63Joint stiffnessFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
64LethargyFAERS: 11US FAERS
65PancreatitisFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
66Tooth LossFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
67Walking aid userFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
68Atypical fractureFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
69Feeling ColdFAERS: 10
Canada Vigilance: 3
Canada Vigilance
US FAERS
70Gastric ulcerFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
71GastritisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
72HypotensionFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
73InfectionFAERS: 10US FAERS
74Mastication disorderFAERS: 10US FAERS
75Myocardial InfarctionFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
76SyncopeFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
77TinnitusFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
78UveitisFAERS: 10US FAERS
79ArthropathyFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
80Cerebrovascular accidentFAERS: 9US FAERS
81Drug dose omissionFAERS: 9US FAERS
82DysphoniaFAERS: 9US FAERS
83Loose toothFAERS: 9US FAERS
84TrismusFAERS: 9US FAERS
85VertigoFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
86ChokingFAERS: 8US FAERS
87Economic problemFAERS: 8US FAERS
88Gastrointestinal PainFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
89PneumoniaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
90Product quality issueFAERS: 8US FAERS
91SwellingFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
92Urinary tract infectionFAERS: 8US FAERS
93AnorexiaFAERS: 7US FAERS
94CataractFAERS: 7US FAERS
95Device breakageFAERS: 7US FAERS
96DiverticulitisFAERS: 7US FAERS
97DysgeusiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
98Impaired driving abilityFAERS: 7US FAERS
99OsteosclerosisFAERS: 7US FAERS
100Throat irritationFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
101ThrombocytopeniaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
102Unevaluable eventFAERS: 7US FAERS
103Angina PectorisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
104Back disorderFAERS: 6US FAERS
105CryingFAERS: 6US FAERS
106CystitisFAERS: 6US FAERS
107DiplopiaFAERS: 6US FAERS
108Drug exposure during pregnancyFAERS: 6US FAERS
109Exposed bone in jawFAERS: 6US FAERS
110Eye irritationFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
111General physical health deteriorationFAERS: 6US FAERS
112Inappropriate schedule of drug administrationFAERS: 6US FAERS
113Intestinal ObstructionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
114IritisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
115Joint Range of Motion DecreasedFAERS: 6US FAERS
116SinusitisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
117StomatitisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
118ThrombosisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
119Visual ImpairmentFAERS: 6
Canada Vigilance: 8
Canada Vigilance
US FAERS
120Alanine Aminotransferase IncreasedFAERS: 5US FAERS
121Aspartate Aminotransferase IncreasedFAERS: 5US FAERS
122Disease recurrenceFAERS: 5US FAERS
123Emotional disorderFAERS: 5US FAERS
124Endodontic procedureFAERS: 5US FAERS
125Eye inflammationFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
126FractureFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
127Gamma-Glutamyltransferase IncreasedFAERS: 5US FAERS
128Grip strength decreasedFAERS: 5US FAERS
129IleusFAERS: 5US FAERS
130Limb injuryFAERS: 5US FAERS
131Lip swellingFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
132Musculoskeletal discomfortFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
133NervousnessFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
134Oral painFAERS: 5US FAERS
135PresyncopeFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
136Purulent dischargeFAERS: 5US FAERS
137Rash erythematousFAERS: 5US FAERS
138Retinal DetachmentFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
139Rheumatoid ArthritisFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
140Tooth InfectionFAERS: 5US FAERS
141UlcerFAERS: 5US FAERS
142Visual disturbanceFAERS: 5US FAERS
143jaundiceFAERS: 5US FAERS
144AsthmaFAERS: 4US FAERS
145Bone resorption test abnormalFAERS: 4US FAERS
146CholestasisFAERS: 4US FAERS
147Cold sweatFAERS: 4US FAERS
148ConjunctivitisFAERS: 4US FAERS
149Deep Vein ThrombosisFAERS: 4US FAERS
150Dental cariesFAERS: 4US FAERS
151DisorientationFAERS: 4US FAERS
152Drug administration errorFAERS: 4US FAERS
153Dry skinFAERS: 4US FAERS
154Flank PainFAERS: 4US FAERS
155HerniaFAERS: 4US FAERS
156Irritable Bowel SyndromeFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
157Joint injuryFAERS: 4US FAERS
158Limb discomfortFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
159Loss of personal independence in daily activitiesFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
160LymphadenopathyFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
161Medication ErrorFAERS: 4US FAERS
162Pain of skinFAERS: 4US FAERS
163Pelvic PainFAERS: 4US FAERS
164Peripheral swellingFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
165PetechiaeFAERS: 4US FAERS
166Polymyalgia RheumaticaFAERS: 4US FAERS
167Primary sequestrumFAERS: 4US FAERS
168PseudarthrosisFAERS: 4US FAERS
169Renal painFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
170Respiratory distressFAERS: 4US FAERS
171RestlessnessFAERS: 4US FAERS
172RetchingFAERS: 4US FAERS
173ScreamingFAERS: 4US FAERS
174SomnolenceFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
175Urinary IncontinenceFAERS: 4US FAERS
176WheezingFAERS: 4US FAERS
177White blood cell count decreasedFAERS: 4US FAERS
178nervous system disorderFAERS: 4US FAERS
179AmnesiaFAERS: 3US FAERS
180Anaphylactic shockFAERS: 3US FAERS
181Blood creatine phosphokinase increasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
182Bone callus excessiveFAERS: 3US FAERS
183Carpal Tunnel SyndromeFAERS: 3US FAERS
184CellulitisFAERS: 3US FAERS
185Cerebral InfarctionFAERS: 3US FAERS
186Drug exposure before pregnancyFAERS: 3US FAERS
187Drug toxicityFAERS: 3US FAERS
188DysgraphiaFAERS: 3US FAERS
189Ear discomfortFAERS: 3US FAERS
190Eye InfectionFAERS: 3US FAERS
191FlushingFAERS: 3US FAERS
192GastroenteritisFAERS: 3US FAERS
193GlossitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
194HyperparathyroidismFAERS: 3US FAERS
195HyperpyrexiaFAERS: 3US FAERS
196ImmobileFAERS: 3US FAERS
197Ligament ruptureFAERS: 3US FAERS
198Macular degenerationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
199Multiple MyelomaFAERS: 3US FAERS
200Muscle strainFAERS: 3US FAERS
201Muscle tightnessFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
202MyositisFAERS: 3US FAERS
203NasopharyngitisFAERS: 3US FAERS
204Nonspecific reactionFAERS: 3US FAERS
205OsteolysisFAERS: 3US FAERS
206OsteopeniaFAERS: 3US FAERS
207OverdoseFAERS: 3US FAERS
208PeriarthritisFAERS: 3US FAERS
209Pharmaceutical product complaintFAERS: 3US FAERS
210Post procedural complicationFAERS: 3US FAERS
211PregnancyFAERS: 3US FAERS
212Pulmonary EmbolismFAERS: 3US FAERS
213Pulmonary thrombosisFAERS: 3US FAERS
214Respiratory FailureFAERS: 3US FAERS
215Skin UlcerFAERS: 3US FAERS
216Skin hypertrophyFAERS: 3US FAERS
217TachycardiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
218Uterine PolypFAERS: 3US FAERS
219Vulvovaginal swellingFAERS: 3US FAERS
220Wrong technique in product usage processFAERS: 3US FAERS
221treatment failureFAERS: 3US FAERS
222Abdominal tendernessFAERS: 2US FAERS
223Accidental overdoseFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
224AngerFAERS: 2US FAERS
225AphagiaFAERS: 2US FAERS
226AphasiaFAERS: 2US FAERS
227AuraFAERS: 2US FAERS
228Bacterial test positiveFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
229Blood albumin decreasedFAERS: 2US FAERS
230Blood alkaline phosphatase increasedFAERS: 2US FAERS
231Blood calcium abnormalFAERS: 2US FAERS
232Blood lactate dehydrogenase increasedFAERS: 2US FAERS
233Blood pressure fluctuationFAERS: 2US FAERS
234Bone density abnormalFAERS: 2US FAERS
235Bone fissureFAERS: 2US FAERS
236Bone formation decreasedFAERS: 2US FAERS
237Breast MicrocalcificationFAERS: 2US FAERS
238BronchitisFAERS: 2US FAERS
239BursitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
240Cardiac ArrestFAERS: 2US FAERS
241CholelithiasisFAERS: 2US FAERS
242ColitisFAERS: 2US FAERS
243Congenital neurological disorderFAERS: 2US FAERS
244Creatinine renal clearance decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
245Cytolytic hepatitisFAERS: 2US FAERS
246DeliriumFAERS: 2US FAERS
247Dental alveolar anomalyFAERS: 2US FAERS
248Depressed Level of ConsciousnessFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
249Device FailureFAERS: 2US FAERS
250Device dislocationFAERS: 2US FAERS
251Drug prescribing errorFAERS: 2US FAERS
252DysuriaFAERS: 2US FAERS
253EczemaFAERS: 2US FAERS
254Enterocolitis bacterialFAERS: 2US FAERS
255EpiscleritisFAERS: 2US FAERS
256Essential HypertensionFAERS: 2US FAERS
257ExophthalmosFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
258Facial PainFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
259FibromyalgiaFAERS: 2US FAERS
260Food PoisoningFAERS: 2US FAERS
261Fracture painFAERS: 2US FAERS
262Gastric DilatationFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
263Gastrointestinal ulcerFAERS: 2US FAERS
264Gingival RecessionFAERS: 2US FAERS
265GingivitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
266HepatitisFAERS: 2US FAERS
267HypertrophyFAERS: 2US FAERS
268HypokinesiaFAERS: 2US FAERS
269HypoventilationFAERS: 2US FAERS
270Implant site abscessFAERS: 2US FAERS
271Inappropriate schedule of product administrationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
272Incorrect dose administeredFAERS: 2US FAERS
273Incorrect drug administration durationFAERS: 2US FAERS
274Joint warmthFAERS: 2US FAERS
275Keratoconjunctivitis SiccaFAERS: 2US FAERS
276LacerationFAERS: 2US FAERS
277Lymphocyte stimulation test positiveFAERS: 2US FAERS
278MYELODYSPLASTIC SYNDROMEFAERS: 2US FAERS
279MalocclusionFAERS: 2US FAERS
280Memory impairmentFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
281Mental status changesFAERS: 2US FAERS
282Muscle CrampFAERS: 2US FAERS
283MyoclonusFAERS: 2US FAERS
284NecrosisFAERS: 2US FAERS
285NephrolithiasisFAERS: 2US FAERS
286Night sweatsFAERS: 2US FAERS
287Non-cardiac chest painFAERS: 2US FAERS
288Oral candidiasisFAERS: 2US FAERS
289Oropharyngeal discomfortFAERS: 2US FAERS
290Orthosis userFAERS: 2US FAERS
291OsteitisFAERS: 2US FAERS
292PallorFAERS: 2US FAERS
293PancytopeniaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
294Pericardial effusionFAERS: 2US FAERS
295PleurisyFAERS: 2US FAERS
296PolymyalgiaFAERS: 2US FAERS
297Poor quality sleepFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
298Post procedural swellingFAERS: 2US FAERS
299Product substitution issueFAERS: 2
Canada Vigilance: 27
Canada Vigilance
US FAERS
300PseudoendophthalmitisFAERS: 2US FAERS
301RhabdomyolysisFAERS: 2US FAERS
302Root canal infectionFAERS: 2US FAERS
303SciaticaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
304Secretion dischargeFAERS: 2US FAERS
305Septic ShockFAERS: 2US FAERS
306Sinus headacheFAERS: 2US FAERS
307Skin irritationFAERS: 2US FAERS
308SneezingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
309Squamous cell carcinomaFAERS: 2US FAERS
310StressFAERS: 2US FAERS
311Therapy non-responderFAERS: 2US FAERS
312ThirstFAERS: 2US FAERS
313ThrombocytosisFAERS: 2US FAERS
314Tooth ErosionFAERS: 2US FAERS
315Urinary RetentionFAERS: 2US FAERS
316Vascular insufficiencyFAERS: 2US FAERS
317Vitamin D DeficiencyFAERS: 2US FAERS
318Vulvovaginal erythemaFAERS: 2US FAERS
319kyphosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
320muscle injuryFAERS: 2US FAERS
321Abdominal adhesionsFAERS: 1US FAERS
322Abdominal massFAERS: 1US FAERS
323AbuliaFAERS: 1US FAERS
324Acquired pyloric stenosisFAERS: 1US FAERS
325AdenocarcinomaFAERS: 1US FAERS
326Adenomatous Polyposis ColiFAERS: 1US FAERS
327Adverse eventFAERS: 1US FAERS
328AgeusiaFAERS: 1US FAERS
329AgitationFAERS: 1US FAERS
330Altered state of consciousnessFAERS: 1US FAERS
331Amyotrophic Lateral SclerosisFAERS: 1US FAERS
332AnhedoniaFAERS: 1US FAERS
333Ankle FractureFAERS: 1US FAERS
334AnosmiaFAERS: 1US FAERS
335AnuriaFAERS: 1US FAERS
336Aortic valve calcificationFAERS: 1US FAERS
337AppendicitisFAERS: 1US FAERS
338ArteritisFAERS: 1US FAERS
339Atrial FlutterFAERS: 1US FAERS
340Auricular swellingFAERS: 1US FAERS
341Autoimmune hepatitisFAERS: 1US FAERS
342Bile duct cancer stage IIIFAERS: 1US FAERS
343Biopsy intestine abnormalFAERS: 1US FAERS
344Bladder cancer recurrentFAERS: 1US FAERS
345Bladder painFAERS: 1US FAERS
346BlepharospasmFAERS: 1US FAERS
347BlindnessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
348Blood creatinine decreasedFAERS: 1US FAERS
349Blood creatinine increasedFAERS: 1US FAERS
350Blood fibrinogen increasedFAERS: 1US FAERS
351Blood glucose decreasedFAERS: 1US FAERS
352Blood immunoglobulin M abnormalFAERS: 1US FAERS
353Blood magnesium decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
354Blood parathyroid hormone decreasedFAERS: 1US FAERS
355Blood phosphorus decreasedFAERS: 1US FAERS
356Blood potassium decreasedFAERS: 1US FAERS
357Blood potassium increasedFAERS: 1US FAERS
358Blood urea increasedFAERS: 1US FAERS
359Blood urine presentFAERS: 1US FAERS
360Bone SarcomaFAERS: 1US FAERS
361Bone erosionFAERS: 1US FAERS
362Brain natriuretic peptide increasedFAERS: 1US FAERS
363Breast cancer recurrentFAERS: 1US FAERS
364Breast discomfortFAERS: 1US FAERS
365BronchopneumoniaFAERS: 1US FAERS
366BronchopneumopathyFAERS: 1US FAERS
367BruxismFAERS: 1US FAERS
368Calcification of muscleFAERS: 1US FAERS
369Calcium deficiencyFAERS: 1US FAERS
370Carbohydrate antigen 27.29 increasedFAERS: 1US FAERS
371CardiomegalyFAERS: 1US FAERS
372Cerebral ventricle dilatationFAERS: 1US FAERS
373Choking sensationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
374CholangitisFAERS: 1US FAERS
375ChromaturiaFAERS: 1US FAERS
376Chronic sinusitisFAERS: 1US FAERS
377Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
378Colon adenomaFAERS: 1US FAERS
379Compression fractureFAERS: 1US FAERS
380Contraindicated drug prescribedFAERS: 1US FAERS
381Coronary Artery DiseaseFAERS: 1US FAERS
382Corynebacterium test positiveFAERS: 1US FAERS
383DeafnessFAERS: 1US FAERS
384DeformityFAERS: 1US FAERS
385Dental FistulaFAERS: 1US FAERS
386Dental discomfortFAERS: 1US FAERS
387Dental prosthesis userFAERS: 1US FAERS
388DermatitisFAERS: 1US FAERS
389DermatomyositisFAERS: 1US FAERS
390Diastolic dysfunctionFAERS: 1US FAERS
391DisabilityFAERS: 1US FAERS
392Disease ProgressionFAERS: 1US FAERS
393Disease complicationFAERS: 1US FAERS
394Drug dispensing errorFAERS: 1US FAERS
395Drug ineffective for unapproved indicationFAERS: 1US FAERS
396DysarthriaFAERS: 1US FAERS
397DyslexiaFAERS: 1US FAERS
398DysplasiaFAERS: 1US FAERS
399Ear congestionFAERS: 1US FAERS
400Ejection Fraction DecreasedFAERS: 1US FAERS
401Electrocardiogram abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
402Emotional distressFAERS: 1US FAERS
403Enterobacter test positiveFAERS: 1US FAERS
404EnterocolitisFAERS: 1US FAERS
405EpicondylitisFAERS: 1US FAERS
406EpistaxisFAERS: 1US FAERS
407Erythema NodosumFAERS: 1US FAERS
408Euphoric moodFAERS: 1US FAERS
409Eye BurnsFAERS: 1US FAERS
410Failure of implantFAERS: 1US FAERS
411Feeling of body temperature changeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
412Food AllergyFAERS: 1US FAERS
413Foreign body traumaFAERS: 1US FAERS
414FrustrationFAERS: 1US FAERS
415Gait inabilityFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
416Gastrointestinal inflammationFAERS: 1US FAERS
417Gastrointestinal obstructionFAERS: 1US FAERS
418Gaze palsyFAERS: 1US FAERS
419Gingival HyperplasiaFAERS: 1US FAERS
420Gingival blisterFAERS: 1US FAERS
421Gingival erythemaFAERS: 1US FAERS
422HemiparesisFAERS: 1US FAERS
423Hepatitis B surface antibody positiveFAERS: 1US FAERS
424HordeolumFAERS: 1US FAERS
425Hormone level abnormalFAERS: 1US FAERS
426HypersomniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
427Hypertensive crisisFAERS: 1US FAERS
428HyperthyroidismFAERS: 1US FAERS
429Hypervitaminosis DFAERS: 1US FAERS
430HypoparathyroidismFAERS: 1US FAERS
431HypothyroidismFAERS: 1US FAERS
432Iatrogenic injuryFAERS: 1US FAERS
433Implant site necrosisFAERS: 1US FAERS
434Implant site reactionFAERS: 1US FAERS
435Inadequate analgesiaFAERS: 1US FAERS
436Incisional herniaFAERS: 1US FAERS
437Incorrect route of drug administrationFAERS: 1US FAERS
438Increased upper airway secretionFAERS: 1US FAERS
439Increased viscosity of bronchial secretionFAERS: 1US FAERS
440Intercepted drug dispensing errorFAERS: 1US FAERS
441Intervertebral Disc DegenerationFAERS: 1US FAERS
442IridocyclitisFAERS: 1US FAERS
443Joint sprainFAERS: 1US FAERS
444KeratopathyFAERS: 1US FAERS
445Labile blood pressureFAERS: 1US FAERS
446LeukocytosisFAERS: 1US FAERS
447Lichen PlanusFAERS: 1US FAERS
448Ligament painFAERS: 1US FAERS
449Limb asymmetryFAERS: 1US FAERS
450Limb crushing injuryFAERS: 1US FAERS
451Lip and/or oral cavity cancerFAERS: 1US FAERS
452LipohypertrophyFAERS: 1US FAERS
453Lower respiratory tract infectionFAERS: 1US FAERS
454Lyme DiseaseFAERS: 1US FAERS
455Lymphocyte count decreasedFAERS: 1US FAERS
456LymphomaFAERS: 1US FAERS
457MalabsorptionFAERS: 1US FAERS
458Medical device complicationFAERS: 1US FAERS
459Medical device implantationFAERS: 1US FAERS
460Medical device removalFAERS: 1US FAERS
461Mental impairmentFAERS: 1US FAERS
462MetrorrhagiaFAERS: 1US FAERS
463Micturition frequency decreasedFAERS: 1US FAERS
464Migraine with AuraFAERS: 1US FAERS
465Monocyte count decreasedFAERS: 1US FAERS
466MonoparesisFAERS: 1US FAERS
467Mood swingsFAERS: 1US FAERS
468Muscle necrosisFAERS: 1US FAERS
469Myoglobin blood increasedFAERS: 1US FAERS
470MyopathyFAERS: 1US FAERS
471Nasal PolypsFAERS: 1US FAERS
472Neisseria infectionFAERS: 1US FAERS
473Nerve injuryFAERS: 1US FAERS
474NeuritisFAERS: 1US FAERS
475Neurological eyelid disorderFAERS: 1US FAERS
476Nodule on extremityFAERS: 1US FAERS
477NoduleFAERS: 1US FAERS
478Ocular discomfortFAERS: 1US FAERS
479OnychoclasisFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
480Open woundFAERS: 1US FAERS
481Ophthalmological examination abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
482Optic NeuritisFAERS: 1US FAERS
483Oral infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
484Oral mucosal erythemaFAERS: 1US FAERS
485Oral torusFAERS: 1US FAERS
486Oropharyngeal swellingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
487Osteogenesis ImperfectaFAERS: 1US FAERS
488OsteomalaciaFAERS: 1US FAERS
489OsteomaFAERS: 1US FAERS
490Osteonecrosis of external auditory canalFAERS: 1US FAERS
491Pancreatic carcinoma stage IIIFAERS: 1US FAERS
492Pancreatic carcinomaFAERS: 1US FAERS
493PapuleFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
494Parapharyngeal abscessFAERS: 1US FAERS
495ParesisFAERS: 1US FAERS
496Pelvic prolapseFAERS: 1US FAERS
497PeriodontitisFAERS: 1US FAERS
498Periorbital disorderFAERS: 1US FAERS
499Personality ChangeFAERS: 1US FAERS
500PharyngitisFAERS: 1US FAERS
501Pharyngolaryngeal PainFAERS: 1US FAERS
502Pharyngolaryngeal discomfortFAERS: 1US FAERS
503Pituitary enlargementFAERS: 1US FAERS
504PneumonitisFAERS: 1US FAERS
505PoisoningFAERS: 1US FAERS
506PolychondritisFAERS: 1US FAERS
507PolymyositisFAERS: 1US FAERS
508Post-traumatic amnestic disorderFAERS: 1US FAERS
509Procalcitonin increasedFAERS: 1US FAERS
510Procedural complicationFAERS: 1US FAERS
511Product difficult to swallowFAERS: 1US FAERS
512Product label issueFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
513Product storage errorFAERS: 1US FAERS
514Product use issueFAERS: 1US FAERS
515Productive CoughFAERS: 1US FAERS
516ProteinuriaFAERS: 1US FAERS
517Psychiatric symptomFAERS: 1US FAERS
518PurpuraFAERS: 1US FAERS
519PyelonephritisFAERS: 1US FAERS
520PyuriaFAERS: 1US FAERS
521Quality of life decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
522Reaction to drug excipientsFAERS: 1US FAERS
523Refusal of treatment by relativeFAERS: 1US FAERS
524Renal ColicFAERS: 1US FAERS
525Renal cystFAERS: 1US FAERS
526Renal tubular necrosisFAERS: 1US FAERS
527Reticulocyte count decreasedFAERS: 1US FAERS
528Retinal vascular thrombosisFAERS: 1US FAERS
529SarcomaFAERS: 1US FAERS
530ScabFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
531Sense of oppressionFAERS: 1US FAERS
532SepsisFAERS: 1US FAERS
533ShockFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
534Shoulder PainFAERS: 1US FAERS
535Single functional kidneyFAERS: 1US FAERS
536Sinus TachycardiaFAERS: 1US FAERS
537Skin PapillomaFAERS: 1US FAERS
538Skin WrinklingFAERS: 1US FAERS
539Skin lesionFAERS: 1US FAERS
540Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
541SluggishnessFAERS: 1US FAERS
542Soft tissue necrosisFAERS: 1US FAERS
543Spinal column stenosisFAERS: 1US FAERS
544SplenomegalyFAERS: 1US FAERS
545SpondylolisthesisFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
546Stevens-Johnson SyndromeFAERS: 1US FAERS
547StuporFAERS: 1US FAERS
548Sudden deathFAERS: 1US FAERS
549Supraventricular tachycardiaFAERS: 1US FAERS
550Suture ruptureFAERS: 1US FAERS
551SynovitisFAERS: 1US FAERS
552Systolic hypertensionFAERS: 1US FAERS
553Temperature intoleranceFAERS: 1US FAERS
554Temporal ArteritisFAERS: 1US FAERS
555TetanyFAERS: 1US FAERS
556Thoracic vertebral fractureFAERS: 1US FAERS
557Thrombocytopenic purpuraFAERS: 1US FAERS
558Thyroid NeoplasmFAERS: 1US FAERS
559ThyroidectomyFAERS: 1US FAERS
560Tongue blisteringFAERS: 1US FAERS
561Tooth ResorptionFAERS: 1US FAERS
562Toxic Epidermal NecrolysisFAERS: 1US FAERS
563Toxic Shock SyndromeFAERS: 1US FAERS
564Transaminases increasedFAERS: 1US FAERS
565Transmission of drug via semenFAERS: 1US FAERS
566Upper respiratory tract congestionFAERS: 1US FAERS
567Urinary hesitationFAERS: 1US FAERS
568Urine output increasedFAERS: 1US FAERS
569VIIth nerve paralysisFAERS: 1US FAERS
570VasculitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
571Venous occlusionFAERS: 1US FAERS
572Ventricular arrhythmiaFAERS: 1US FAERS
573Ventricular hypertrophyFAERS: 1US FAERS
574Vertebral wedgingFAERS: 1US FAERS
575VertebroplastyFAERS: 1US FAERS
576Vitreous floatersFAERS: 1US FAERS
577Vocal Cord ParalysisFAERS: 1US FAERS
578Wheelchair userFAERS: 1US FAERS
579Wrong technique in drug usage processFAERS: 1US FAERS
580X-ray abnormalFAERS: 1US FAERS
581furuncleFAERS: 1US FAERS
582neurofibromaFAERS: 1US FAERS
583pH urine decreasedFAERS: 1US FAERS
584AcneCanada Vigilance: 1Canada Vigilance
585Antinuclear antibody negativeCanada Vigilance: 1Canada Vigilance
586BlepharitisCanada Vigilance: 1Canada Vigilance
587Blood creatine increasedCanada Vigilance: 1Canada Vigilance
588Blood iron increasedCanada Vigilance: 1Canada Vigilance
589Bone swellingCanada Vigilance: 1Canada Vigilance
590Bowel movement irregularityCanada Vigilance: 1Canada Vigilance
591Cardiac FlutterCanada Vigilance: 1Canada Vigilance
592Concomitant disease aggravatedCanada Vigilance: 1Canada Vigilance
593Corneal lesionCanada Vigilance: 1Canada Vigilance
594Epigastric discomfortCanada Vigilance: 1Canada Vigilance
595Extremity contractureCanada Vigilance: 2Canada Vigilance
596Eyelid margin crustingCanada Vigilance: 1Canada Vigilance
597GlaucomaCanada Vigilance: 1Canada Vigilance
598Head discomfortCanada Vigilance: 3Canada Vigilance
599HungerCanada Vigilance: 1Canada Vigilance
600Incorrect route of product administrationCanada Vigilance: 1Canada Vigilance
601Injection site painCanada Vigilance: 1Canada Vigilance
602Intestinal resectionCanada Vigilance: 1Canada Vigilance
603LaryngitisCanada Vigilance: 1Canada Vigilance
604LeukopeniaCanada Vigilance: 1Canada Vigilance
605LichenificationCanada Vigilance: 1Canada Vigilance
606MenorrhagiaCanada Vigilance: 1Canada Vigilance
607Motion SicknessCanada Vigilance: 1Canada Vigilance
608NeuralgiaCanada Vigilance: 1Canada Vigilance
609Neutrophil chemotaxis abnormalCanada Vigilance: 2Canada Vigilance
610Neutrophil function test abnormalCanada Vigilance: 2Canada Vigilance
611Non-infectious endophthalmitisCanada Vigilance: 1Canada Vigilance
612Product size issueCanada Vigilance: 1Canada Vigilance
613Puncture site swellingCanada Vigilance: 1Canada Vigilance
614Pustular psoriasisCanada Vigilance: 1Canada Vigilance
615RosaceaCanada Vigilance: 1Canada Vigilance
616ScleritisCanada Vigilance: 4Canada Vigilance
617TonsillitisCanada Vigilance: 1Canada Vigilance
618Unresponsive to stimuliCanada Vigilance: 1Canada Vigilance
619Vessel puncture site bruiseCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.